<DOC>
	<DOCNO>NCT00005864</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness chloroquinoxaline sulfonamide treat patient stage IV colorectal cancer .</brief_summary>
	<brief_title>Chloroquinoxaline Sulfonamide Treating Patients With Stage IV Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I. Assess antitumor activity toxicity chloroquinoxaline sulfonamide patient stage IV colorectal cancer . OUTLINE : This multicenter study . Patients receive chloroquinoxaline sulfonamide IV 1 hour weekly 4 consecutive week . Treatment continue every 6 week absence disease progression unacceptable toxicity . Patients follow least 30 day . PROJECTED ACCRUAL : A total 16-25 patient accrue study within 8 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Sulfanilamide</mesh_term>
	<mesh_term>Sulfanilamides</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm stage IV colorectal cancer Measurable disease define lesion measure least 20 mm one dimension use conventional technique least 10 mm spiral CT scan include : Bone lesion Leptomeningeal disease Ascites Pleural/pericardial effusion Inflammatory breast disease Lymphangitis cutis/pulmonis Abdominal mass confirm followed imaging technique Cystic lesion Recurrent disease allow adjuvant chemotherapy recurrence occur least 6 month completion therapy No known brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Karnofsky 60100 % Life expectancy : Greater 12 week Hematopoietic : WBC least 3,000/mm3 Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin normal AST/ALT great 2.5 time upper limit normal Renal : Creatinine normal Cardiovascular : No history symptomatic congestive heart failure , unstable angina , cardiac arrhythmia ( e.g. , supraventricular tachycardia atrial fibrillation ) Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No significant episode hypoglycemia past 6 month No known allergy compound similar chemical biologic composition chloroquinoxaline sulfonamide No known glucose6 phosphate deficiency hemolytic anemia No uncontrolled concurrent illness ( e.g. , active infection ) No concurrent psychiatric illness social condition would preclude compliance PRIOR CONCURRENT THERAPY : Biologic therapy : One prior biologic therapy allow Chemotherapy : See Disease Characteristics No one prior chemotherapy metastatic disease adjuvant treatment At least 4 week since prior chemotherapy ( 6 week nitrosoureas mitomycin ) recover Endocrine therapy : No concurrent oral hypoglycemics insulin Radiotherapy : At least 4 week since prior radiotherapy recover Surgery : Not specify Other : No concurrent investigational agent No concurrent combination antiretroviral treatment HIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2002</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
</DOC>